未知生产厂商
Lefradafiban is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.
Lefradafiban is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.
GPIIb/IIIa inhibitors, such as lefradafiban, block the final common pathway of platelet aggregation.
For the treatment of unstable angina.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
